6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... visualabstract #table ... #CVD #CKD
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Angina, HFpEF, ... HFrEF, AFib, TAA ... Dissection • CKD ... #pharmacology #table ... #management
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
in HFrEF and CKD ... Class I pillars of HFrEF ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... guideline-directed medical ... heart failure; HFpEF ... ejection fraction; HFrEF
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... Ejection Fraction (HFrEF ... Guideline-Directed Medical ... patients with HFrEF ... #HFrEF #Pharmacology
HFrEF: Guideline Directed Medical Therapy

"Must Be On"
 • ACEI, ARB, or ARNI AND select Beta Blockers
HFrEF: Guideline ... Directed Medical ... American patients #hfref ... #management #medications ... #GDMT